KD033 stimulated intra-tumoral cytotoxicity responses in both human PD-L1- and PD-L1+ MC38 tumors; however, KD033 treatment resulted in different tumor transcriptomic changes in hPDL1+ compared to hPDL1- MC38 tumors. Here, CD274 is linked to neoplasm.